Telix Innovations SA

Booth: B11

Main Sponsor

Belgium

Telix Innovations SA is the European hub of Telix Pharmaceuticals, a commercial-stage biopharmaceutical company developing and commercializing theranostic radiopharmaceuticals. Telix focuses on precision oncology, with a pipeline targeting prostate, kidney, brain, and musculoskeletal cancers, as well as bone marrow conditioning.

Combining targeted radiotherapy and diagnostics, Telix delivers personalized care through imaging agents like Illuccix® and advanced therapeutic platforms. With a strong global manufacturing and distribution network, including a new state-of-the-art facility in Belgium, Telix is shaping the future of radiopharmaceuticals.